Zacks6h fa · leggi qui →
DexCom (DXCM) Recently Broke Out Above the 20-Day Moving Average
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?…
Zacks7h fa · leggi qui →
DexCom, Inc. (DXCM) Hit a 52 Week High, Can the Run Continue?
DexCom (DXCM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.…
Simply Wall St.1g fa · leggi qui →
DexCom (DXCM) Stock Sees Fair Value Lift After Analyst Target Increases
DexCom’s fair value estimate has shifted from US$85.24 to US$91.64, marking a moderate uplift in the price target range currently referenced for the stock. This move lines up with recent analyst comme…
Simply Wall St.2g fa · leggi qui →
Why DexCom (DXCM) Is Up 16.6% After Raising 2026 Outlook And Expanding Type 2 Access
In late July 2026, DexCom reported second-quarter results showing higher sales and earnings than a year earlier and raised its full-year 2026 revenue outlook to US$5.18 billion–US$5.25 billion, implyi…
StockStory2g fa · leggi qui →
DXCM Q2 Deep Dive: Expanded Access and Product Updates Drive Growth
Medical device company DexCom (NASDAQ:DXCM) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 13.1% year on year to $1.31 billion. The company expects the full year’…
Zacks3g fa · leggi qui →
DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise
DXCM's Q2 earnings and revenues beat estimates as global demand, broader access and margin expansion fuel stronger 2026 guidance.…
Medical Device Network3g fa · leggi qui →
Dexcom tweaks full-year outlook after reporting 13% growth in Q2
Following the release of its Q2 results on 30 July, Dexcom's company’s shares on the Nasdaq rose over 8% to $81.04 at market open on 31 July.…
StockStory3g fa · leggi qui →
Why Is DexCom (DXCM) Stock Rocketing Higher Today
Shares of medical device company DexCom (NASDAQ:DXCM) jumped 10.9% in the morning session after the company reported strong second-quarter results and slightly raised its full-year financial outlook.…
GuruFocus.com3g fa · leggi qui →
DexCom Inc (DXCM) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...
DexCom Inc (DXCM) delivered 13% revenue growth and raised full-year guidance, driven by strong international performance and improved margins.…
Motley Fool3g fa · leggi qui →
DexCom (DXCM) Q2 2026 Earnings Call Transcript
Revenue hit $1.31 billion with strong international growth and margin expansion.…